- Trials with a EudraCT protocol (44,335)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
44,335 result(s) found.
Displaying page 873 of 2,217.
EudraCT Number: 2008-002264-34 | Sponsor Protocol Number: 6078-PG-PSC-168 | Start Date*: 2008-08-19 | ||||||||||||||||
Sponsor Name:LETI Pharma GmbH | ||||||||||||||||||
Full Title: Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis wit... | ||||||||||||||||||
Medical condition: Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) LT (Completed) PL (Completed) BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-005891-28 | Sponsor Protocol Number: CORICA | Start Date*: 2008-10-04 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: Perspective evaluation on the role practiced by three different contraceptive hormonal on l I risk cardiovascular in young women: impact on the sensibility' insulinica | |||||||||||||
Medical condition: GIOVANI DONNE TRA 18 E 35 ANNI | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002324-15 | Sponsor Protocol Number: P01092 | Start Date*: 2007-09-04 | |||||||||||
Sponsor Name:University of East Anglia | |||||||||||||
Full Title: The efficacy and safety of co-trimoxazole therapy in patients with idiopathic interstitial pneumonia | |||||||||||||
Medical condition: Idiopathic Interstitial Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003035-22 | Sponsor Protocol Number: ACP-103-015 | Start Date*: 2008-11-05 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) SE (Completed) BE (Completed) AT (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000826-37 | Sponsor Protocol Number: AZ3110865 | Start Date*: 2008-07-14 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: Study AZ3110865, a study comparing SB-742457 or donepezil versus placebo in subjects with mild-to-moderate Alzheimer’s disease | |||||||||||||
Medical condition: Alzheimer's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) EE (Completed) BG (Completed) DE (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001002-16 | Sponsor Protocol Number: EFC10743 | Start Date*: 2008-09-29 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, 24-week study followed by an extension assessing the efficacy and safety of AVE0010 in two titration regimens on top of ... | |||||||||||||
Medical condition: Type II Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SK (Completed) IT (Completed) EE (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000546-31 | Sponsor Protocol Number: A3051104 | Start Date*: 2008-07-16 | |||||||||||
Sponsor Name:Pfizer Ltd, Ramsgate Road,Sandwich,Kent CT13 9NJ | |||||||||||||
Full Title: A RANDOMIZED, MULTICENTRE, DOUBLE BLIND, PLACEBO CONTROLLED STUDY EVALUATING THE EFFICACY OF VARENICLINE IN CESSATION OF ORAL TOBACCO USE | |||||||||||||
Medical condition: Cessation of oral smokeless tobacco use in current non-smokers. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011411-21 | Sponsor Protocol Number: BVF-324-302 | Start Date*: 2009-07-17 | |||||||||||
Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre... | |||||||||||||
Medical condition: Premature Ejaculation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: HU (Prematurely Ended) BG (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001611-32 | Sponsor Protocol Number: 153006 | Start Date*: 2008-04-25 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A multi-center cardiac safety study of subjects who participated in Organon sponsored Phase 1 and Phase 2 completed and discontinued trials with Org 24448 (Protocols: 22601;22602;22603; 153001;1530... | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007007-32 | Sponsor Protocol Number: IGD 001 | Start Date*: 2007-12-13 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Efficacy of IVIG in the treatment of treatment-resistent painful neuropathy | |||||||||||||
Medical condition: Painful Neuropathies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004497-11 | Sponsor Protocol Number: P070131 | Start Date*: 2008-08-21 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Impact des Inhibiteurs de Tyrosine Kinase sur la fertilité masculine. GLIFERTI | |||||||||||||
Medical condition: LMC et GIST traités par un inhibiteur de tyrosine kinase en monothérapie. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000069-41 | Sponsor Protocol Number: THCHOG-2008-01 | Start Date*: 2008-04-09 |
Sponsor Name:Erasmus MC | ||
Full Title: Regulation of colloid osmotic pressure during cardiopulmonary bypass in infants: prospective randomised trial | ||
Medical condition: Regulation of COP during CPB in infants | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006227-12 | Sponsor Protocol Number: SPON408-07 | Start Date*: 2008-03-18 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: A randomised, placebo controlled study of nebulised magnesium in acute severe asthma in children | |||||||||||||
Medical condition: Acute severe asthma | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003361-40 | Sponsor Protocol Number: 0462-081 | Start Date*: 2007-10-16 | |||||||||||
Sponsor Name:Merck & Co., Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Clinical Trial to Study the Efficacy and Safety of MK-0462 / Rizatriptan 10 mg for the Early Treatment of Acute Migraine | |||||||||||||
Medical condition: Treatment of Acute Migraine when pain severity is mild. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002085-63 | Sponsor Protocol Number: LIDO-CLOR | Start Date*: 2008-05-13 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: TREATMENT OF CHRONIC PAIN BY NEUROMODULATION WITH LOCAL ANESTHETIC (NEURALTHERAPY) IN OPERATED AND / OR IRRADIATED PATIENTS FOR HEAD AND NECK, BREST AND, INTRATHROCIC NEOPLASM | |||||||||||||
Medical condition: CHRONIC PAIN IN OPERATED AND / OR IRRADIATED PATIENTS FOR HEAD AND NECK, BREST AND, INTRATHROCIC NEOPLASM | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002571-40 | Sponsor Protocol Number: 231006 | Start Date*: 2007-05-18 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A randomized, double-blind, active and placebo controlled trial to compare the relative analgesic efficacy and safety of a single intravenous dose of Org 28611 3.0 µg/kg, morphine sulfate 0.12 mg/... | |||||||||||||
Medical condition: Postoperative analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000451-97 | Sponsor Protocol Number: RABGRD1002 | Start Date*: 2008-04-25 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabeprazole in Pediatric Subjects with GERD 1 to 11 Years old, inclusive | |||||||||||||
Medical condition: Pediatric subjects with GERD (endoscopically proven) and have had endoscopic examination as part of their diagnostic evaluation; 1 to 11 Years Old, inclusive | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002632-15 | Sponsor Protocol Number: BAK-08 | Start Date*: 2008-10-10 |
Sponsor Name:Birken GmbH | ||
Full Title: Randomized, multicenter, double blind study to compare the efficacy and tolerability of Oleogel-S-10 for 3 months versus placebo only in patients with mild to moderate ac-tinic keratoses located at... | ||
Medical condition: Die Studie ist eine randomisierte, multizentrische, doppelt verblindete Studie zum Vergleich der Wirksamkeit und Verträglichkeit einer Behandlung mit Oleogel-S-10 über 3 Monate vs. Placebo bei Pati... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007662-37 | Sponsor Protocol Number: P070603 | Start Date*: 2008-05-20 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Facteurs de variabilité des doses de méthadone nécessaires pour atteindre l'équilibre du traitement de substitution de la dépendance aux opiacés : Approches phénotypique et génotypique des biomarq... | |||||||||||||
Medical condition: - Patient équilibré sous traitement de substitution par méthadone depuis au moins trois mois | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004746-33 | Sponsor Protocol Number: 310123 | Start Date*: 2008-09-17 | |||||||||||
Sponsor Name:Bayer HealthCare Pharmaceuticals INC | |||||||||||||
Full Title: A multicenter, randomized, double-blind, crossover, phase 3 study to determine the safety and efficacy of gadobutrol 1.0 molar (Gadovist®) in patients referred for contrast-enhanced MRI of the cent... | |||||||||||||
Medical condition: Male and female patients of any ethnic group who are referred for a contrast-enhanced MRI of the CNS based on current clinical symptoms or results of a previous imaging procedure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
